Lyell Immunopharma LYEL
NASDAQ LYEL
$9.39 +0.01 (+0.11%)
At close: Oct 23, 2026 · 4:00 PM EDT

Lyell Immunopharma (LYEL) Gains from Investment Securities (2022 - 2025)

Updated

Analysis

Lyell Immunopharma (LYEL) Gains from Investment Securities (2022 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn
10 Lyell Immunopharma 219.70 Mn -805.27 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -1,000.00
Sep 30, 2025 -1,000.00
Jun 30, 2025 -2,000.00
Mar 31, 2025 -26,000.00
Dec 31, 2024 -17,000.00
Mar 31, 2024 1.54 Mn
Dec 31, 2023 12.92 Mn
Jun 30, 2023 -2.92 Mn
Mar 31, 2023 -10.00 Mn
Sep 30, 2022 -5.00 Mn
API Access

Lyell Immunopharma Gains from Investment Securities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-investment-securities&ticker=LYEL&period=max&api_key=YOUR_API_KEY